344 related articles for article (PubMed ID: 29935174)
1. Strategies for the treatment of HBV/HDV.
Krause A; Haberkorn U; Mier W
Eur J Pharmacol; 2018 Aug; 833():379-391. PubMed ID: 29935174
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis D: A Review.
Negro F; Lok AS
JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
[TBL] [Abstract][Full Text] [Related]
3. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
Ferrante ND; Lo Re V
Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
[TBL] [Abstract][Full Text] [Related]
5. [The return of the hepatitis delta virus].
Zoutendijk R; de Jonge PJ; de Man RA
Ned Tijdschr Geneeskd; 2016; 160():D70. PubMed ID: 27405575
[TBL] [Abstract][Full Text] [Related]
6. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
Goyal A; Murray JM
Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
[TBL] [Abstract][Full Text] [Related]
7. [Chronic hepatitis B and D (delta) : Current and future treatments].
Wortmann N; Höner Zu Siederdissen C; Cornberg M
Internist (Berl); 2018 Jun; 59(6):519-527. PubMed ID: 29761292
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of in vivo hepatitis D virus infection.
Goyal A; Murray JM
J Theor Biol; 2016 Jun; 398():9-19. PubMed ID: 27012516
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
10. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
11. [Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances].
Romeo R
Recenti Prog Med; 2010 Feb; 101(2):52-6. PubMed ID: 20433000
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed country.
Sellier PO; Maylin S; Brichler S; Berçot B; Lopes A; Chopin D; Pogliaghi M; Munier AL; Delcey V; Simoneau G; Evans J; Gordien E; Simon F; Bergmann JF
Liver Int; 2018 Apr; 38(4):611-618. PubMed ID: 28834623
[TBL] [Abstract][Full Text] [Related]
13. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
14. A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection.
Buchmann B; Döhner K; Schirdewahn T; Sodeik B; Manns MP; Wedemeyer H; Ciesek S; von Hahn T
Antiviral Res; 2017 May; 141():116-123. PubMed ID: 28223128
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of and New Therapies for Hepatitis D.
Koh C; Heller T; Glenn JS
Gastroenterology; 2019 Jan; 156(2):461-476.e1. PubMed ID: 30342879
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis delta and HIV infection.
Soriano V; de Mendoza C; Treviño A; Ramos-Rincón JM; Moreno-Torres V; Corral O; Barreiro P
Liver Int; 2023 Aug; 43 Suppl 1():108-115. PubMed ID: 35748639
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Delta Hepatitis: Today and in the Future - A review.
Bahcecioglu IH; Sahin A
Infect Dis (Lond); 2017 Apr; 49(4):241-250. PubMed ID: 28092214
[TBL] [Abstract][Full Text] [Related]
18. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
Winer BY; Shirvani-Dastgerdi E; Bram Y; Sellau J; Low BE; Johnson H; Huang T; Hrebikova G; Heller B; Sharon Y; Giersch K; Gerges S; Seneca K; Pais MA; Frankel AS; Chiriboga L; Cullen J; Nahass RG; Lutgehetmann M; Toettcher JE; Wiles MV; Schwartz RE; Ploss A
Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950446
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of hepatitis B and delta virus infection.
Dandri M; Lütgehetmann M
J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in delta virus infection.
Roche B; Samuel D
Semin Liver Dis; 2012 Aug; 32(3):245-55. PubMed ID: 22932973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
